首页> 外国专利> UROTHELIAL CELL INDUCTION AGENT AND METHOD FOR INDUCING UROTHELIAL CELLS

UROTHELIAL CELL INDUCTION AGENT AND METHOD FOR INDUCING UROTHELIAL CELLS

机译:尿路上细胞诱导剂及诱导尿路皮细胞的方法

摘要

The purpose of the present invention is to provide: a method for preparing urothelial cells that are applicable to the treatment of urinary system diseases, in particular diseases caused by damaged urothelial cells, and diseases due to the loss or dysfunction of urothelial cells; urothelial cells prepared by this method; and a medium for inducing (preparing) urothelial cells. In the present invention, urothelial cells prepared by this method for inducing urothelial cells are applicable for the treatment of urinary system diseases, the method including a step for introducing at least one selected from the group consisting of FOXA1 (Forkhead box A1) gene or an expression product thereof, TP63 (tumor protein P63) gene or an expression product thereof, MYCL (L-Myc) gene or an expression product thereof, and KLF4 (Kruppel-like factor 4) gene or an expression product thereof into mammalian somatic cells as an exogenous factor.
机译:本发明的目的是提供:一种制备适用于治疗泌尿系统疾病的尿液细胞的方法,特别是由尿道细胞受损引起的疾病,以及由于尿尿细胞的损失或功能障碍引起的疾病;通过该方法制备的尿路皮细胞;和诱导(准备)尿路上皮细胞的培养基。在本发明中,通过该方法制备的尿液细胞制备的尿液细胞适用于治疗泌尿系统疾病,该方法包括引入选自FoxA1(Forkhead Box A1)基因或AN的基团中的至少一种方法其表达产物,TP63(肿瘤蛋白P63)基因或其表达产物,MyCl(L-MYC)基因或其表达产物,以及KLF4(Kruppel样因子4)基因或其表达产物在哺乳动物体细胞中作为外源性因素。

著录项

  • 公开/公告号WO2021039972A1

    专利类型

  • 公开/公告日2021-03-04

    原文格式PDF

  • 申请/专利权人 CELLAXIA INC.;

    申请/专利号WO2020JP32644

  • 申请日2020-08-28

  • 分类号A61K48;A61P13;A61P13/02;A61P13/10;A61P35;A61P43;C12N5/10;C12N15/12;C12N15/85;A61K35/22;A61K35/76;

  • 国家 JP

  • 入库时间 2022-08-24 17:32:28

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号